Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2333074 | 1.00 | ALOX15 (0.31) | ALOX15TDP1CYP11B1CYP11B2 | |
| SCHEMBL7547799 | 0.82 | NPC1 (0.37) | ALOX15TDP1CYP11B1CYP11B2 | |
| SCHEMBL14065330 | 0.78 | CALM1 (0.39) | ALOX15TDP1CYP11B1CYP11B2 | |
| SCHEMBL3345797 | 0.78 | GRM5 (0.33) | CYP11B1CYP11B2 | |
| SCHEMBL9215304 | 0.78 | GABRA1 (0.35) | — | |
| SCHEMBL8660096 | 0.76 | PTGS2 (0.35) | ALOX15TDP1 | |
| SCHEMBL4714309 | 0.74 | CYP11B1 (0.36) | TDP1CYP11B1CYP11B2 | |
| SCHEMBL19856524 | 0.72 | KMT2A (0.50) | — | |
| SCHEMBL30718118 | 0.72 | KMT2A (0.53) | ALOX15TDP1 | |
| SCHEMBL2333513 | 0.72 | KMT2A (0.53) | ALOX15TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2376472-A1 | PROCESS FOR MANUFACTURING 5-FORMYL-PYRIDINE-2,3-DICARBOXYLIC ACID ESTERS | BASF SE (DE) | 2011-10-19 | — | — | EP | disclosed |
| US-20110245505-A1 | Process for Manufacturing 5-Formyl-Pyridine-2,3-Dicarboxylic Acid Esters | BASF SE (DE) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110245505-A1 | Process for Manufacturing 5-Formyl-Pyridine-2,3-Dicarboxylic Acid Esters | ADH1C, ADH5, AOX1 | ALOX15 54/4885TDP1 3217/4885CYP11B1 165/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.